Boit C.F. David’s Pfizer PFE Stock Holding History

Boit C.F. David’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Hold	49,103	–	–	0.5%	45
2026 Q1	$1.38M	Hold	49,103	–	–	0.61%	38
2025 Q4	$1.25M	Hold	49,103	–	–	0.54%	40
2025 Q3	$1.25M	Hold	49,103	–	–	0.57%	39
2025 Q2	$1.19M	Hold	49,103	–	–	0.57%	37
2025 Q1	$1.24M	Hold	49,103	–	–	0.62%	37
2024 Q4	$1.3M	Hold	49,103	–	–	0.53%	36
2024 Q3	$1.4M	Hold	49,103	–	–	0.7%	35
2024 Q2	$1.37M	Hold	49,103	–	–	0.72%	34
2024 Q1	$1.33M	Hold	49,103	–	–	0.73%	34
2023 Q4	$1.46M	Buy	49,103 +4,761	+11%	+$144K	0.82%	31
2023 Q3	$1.5M	Hold	44,342	–	–	1.03%	28
2023 Q2	$1.63M	Hold	44,342	–	–	1.08%	27
2023 Q1	$1.78M	Hold	44,342	–	–	1.22%	27
2022 Q4	$2.27M	Hold	44,342	–	–	1.62%	21
2022 Q3	$1.94M	Buy	+44,342	New	+$2.15M	1.58%	21
2022 Q1	$2.63M	Sell	44,342 -276	-0.6%	-$14.3K	1.73%	22
2021 Q4	$2.63M	Hold	44,618	–	–	1.67%	23
2021 Q3	$1.92M	Hold	44,618	–	–	1.31%	26
2021 Q2	$1.75M	Buy	+44,618	New	+$1.74M	1.33%	25

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boit C.F. David's PFE Position: Q2 2026 in Review

Boit C.F. David held its Pfizer (PFE) position steady in Q2 2026 at 49,103 shares worth $1.18M. The position accounts for 0.5% of the portfolio, ranked #45.

Boit C.F. David first reported a position in PFE in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.63M in Q1 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Boit C.F. David held 49,103 shares of Pfizer worth $1.18M as of Q2 2026.
Boit C.F. David left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.5% of Boit C.F. David's portfolio in Q2 2026, its #45 holding.
Boit C.F. David first reported a position in Pfizer in Q2 2021 and has held it in 20 quarters since.
Boit C.F. David's Pfizer position peaked at $2.63M in Q1 2022.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boit C.F. David's 13F filing for Q2 2026, filed 30 Jul 2026.